产品名称 | NebuSelect™ Recombinant Mouse LOX1, His-tag |
---|---|
目录号 | NBL-242335 |
别名 | LOX1; Ox-LDL receptor 1; LOX-1; CLEC8A; LOX1; OLR1; LOXIN; SR-E1; SCARE1; SLOX1 |
外观 | see COA |
分子量 | Arg60-Ile363 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9EQ09 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242335-100ug | 100ug | Inquire | Inquire | |
NBL-242335-1mg | 1mg | Inquire | Inquire | |
NBL-242335-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse LOX1, His-tag
Catalog#:
NBL-242335
Description:
NebuSelect™ Recombinant Mouse LOX1, His-tag(Cat#NBL-242335) is expressed in HEK293 with His tag at the N-Terminus.It contains Arg60-Ile363.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 36.1 kDa. Due to glycosylation, the protein migrates to 55-63 kDa based on Bis-Tris PAGE result.
Target Name:
LOX1; Ox-LDL receptor 1; LOX-1; CLEC8A; LOX1; OLR1; LOXIN; SR-E1; SCARE1; SLOX1
Target Information:
LOX-1 is a transmembrane glycoprotein that binds to and internalizes ox-LDL.LOX-1 gene deletion in mice and anti-LOX-1 therapy has been shown to decrease inflammation, oxidative stress and atherosclerosis. LOX-1 deletion also results in damage from ischemia, making LOX-1 a promising target of therapy for atherosclerosis and related disorders. In this article we focus on the different mechanisms for regulation, signaling and the various effects of LOX-1 in contributing to atherosclerosis.
Amino Acid Sequence:
Arg60-Ile363
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.